Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain
Clinical trial NCT04372121 · TERMINATED
Trial details
- NCT number
- NCT04372121
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-23
- Primary completion
- 2021-01-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.